Skip to main content
WatchRoster

Laima Akstinaitė Filmography

ActressBORN 1989VILNIUS3 FILMS IN DB

LaimaAkstinaitė

Known for Acting ·

3
FILMS IN DB
$0
TOTAL VALUE
0
PRICED
AVG VALUE
BEST FORMAT

BIOGRAPHY

Laima Akstinaitė has carved a niche for herself in the realm of independent cinema, captivating audiences with her powerful performances in thought-provoking narratives. Her standout role in "Mothers" (2021) garnered critical acclaim and highlighted her ability to convey deep emotional complexity, making it a must-have for collectors who appreciate films that challenge societal norms. Another significant entry in her filmography is "Maternity Leave," where she explores the intricacies of motherhood with a fresh perspective, further establishing her as a formidable talent in contemporary film. Collectors are particularly drawn to Akstinaitė's work for its blend of artistry and authenticity, often reflected in the limited physical media releases that accompany her films. Both "Mothers" and "Maternity Leave" have become sought-after titles, frequently featured in discussions about the evolution of female-led narratives in cinema. As the home video market continues to thrive, Laima Akstinaitė's contributions resonate deeply with enthusiasts eager to celebrate and preserve these compelling stories on their shelves.

FILMS BY DECADE

FULL FILMOGRAPHY

3 films
FAQ

Frequently Asked Questions

What is Laima Akstinaitė known for?

Laima Akstinaitė is known for her acting roles in films such as 'Mothers' (2021) as Daughter, 'Maternity Leave', and 'Blueberry Bruise' (2024) as Simona.

What genres does Laima Akstinaitė's filmography span?

Laima Akstinaitė's filmography spans the Drama genre.

What is the range of Laima Akstinaitė's work in terms of years?

Laima Akstinaitė's work covers the years from 2021 to 2024.

How many films are listed in Laima Akstinaitė's filmography?

Laima Akstinaitė has 3 films listed in her filmography.

What decade is Laima Akstinaitė most active in?

Laima Akstinaitė is most active in the 2020s.